Trial Profile
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary)
- Indications Musculoskeletal pain
- Focus Registrational; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 15 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 15 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.